Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of maraviroc effect on HIV-1 latency and reservoir in patients on HAART
2007-003995-21Phase 2Completed
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of maraviroc in human immunodeficiency virus infection (HIV), sponsored by Fundación para la Investigación Biomédica del Hospital Universitario Ramón y Cajal. Primary endpoints: Size of latent HIV-1 reservoir and Frequency of resting infected CD4+ T cells. Started Sep 2007; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2007-003995-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003995-21.